HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials.

AbstractAIM:
To report on the multidisciplinary approach, focusing specifically on the role of the interventional radiologist (IR), used to support the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) and BATTLE-2 trials.
MATERIALS AND METHODS:
Patients who underwent percutaneous image-guided biopsy for the BATTLE and BATTLE-2 trials were reviewed. A radiology-based, three-point, lesion-scoring system was developed and used by two IRs. Lesions were given a score of 3 (most likely to yield sufficient material for biomarker analysis) if they met the following criteria: size >2 cm, solid mass, demonstrated imaging evidence of viability, and were technically easy to sample. Lesions not meeting all four criteria were scored 2 with the missing criteria noted as negative factors. Lesions considered to have risks that outweighed potential benefits receive a score of 1 and were not biopsied. Univariate and multivariate analyses were performed to evaluate the score's ability to predict successful yield for biomarker adequacy.
RESULTS:
A total of 555 biopsies were performed. The overall yield for analysis of the required biomarkers was 86.1% (478/555), and 84% (268/319) and 88.9% (210/236) for BATTLE and BATTLE-2, respectively (p=0.09). Lesions receiving a score of 3 were adequate for biomarker analysis in 89% of cases. Lesions receiving a score of 2 with more than two negative factors were adequate for molecular analysis in 69.2% (IR1, p=0.03) and 74% (IR2, p=0.04) of cases. The two IRs scored 78.4% of the lesions the same indicating moderate agreement (kappa=0.55; 95% confidence interval [CI]: 0.48, 0.61).
CONCLUSIONS:
IRs add value to clinical trial teams by optimising lesions selected for biopsy and biomarker analysis.
AuthorsA L Tam, V Papadimitrakopoulou, I I Wistuba, J J Lee, J E Ensor, E S Kim, N Kalhor, G R Blumenschein Jr, A S Tsao, J V Heymach, R S Herbst, M E Hicks, W K Hong, S Gupta
JournalClinical radiology (Clin Radiol) Vol. 76 Issue 2 Pg. 155.e25-155.e34 (Feb 2021) ISSN: 1365-229X [Electronic] England
PMID33268083 (Publication Type: Journal Article)
CopyrightCopyright © 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Topics
  • Aged
  • Biopsy, Fine-Needle
  • Carcinoma, Non-Small-Cell Lung (diagnostic imaging, pathology)
  • Clinical Trials as Topic
  • Female
  • Humans
  • Image-Guided Biopsy
  • Lung (diagnostic imaging, pathology)
  • Lung Neoplasms (diagnostic imaging, pathology)
  • Male
  • Middle Aged
  • Patient Care Team
  • Radiology, Interventional (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: